Pages that link to "Q34230858"

The following pages link to Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients (Q34230858):

Displaying 23 items.

• Interleukin-35: Expanding Its Job Profile (Q26829619) (← links)
• Lessons learned from gene expression profiling of cutaneous T-cell lymphoma (Q26865858) (← links)
• Targeting TGF-β signaling in cancer (Q27012443) (← links)
• Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy (Q27021750) (← links)
• TGF-β sensitivity restrains CD8+ T cell homeostatic proliferation by enforcing sensitivity to IL-7 and IL-15 (Q27327079) (← links)
• TGF-beta and cancer. (Q33804136) (← links)
• Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation. (Q33987080) (← links)
• Altered Response to and Production of TGF-β by B Cells from Autoimmune NZB Mice (Q34436598) (← links)
• Lymphoma-like T cell infiltration in liver is associated with increased copy number of dominant negative form of TGFβ receptor II. (Q34474492) (← links)
• Studies of normal and neoplastic lymphocytes (Q34792478) (← links)
• TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells (Q35668744) (← links)
• Consistent loss of functional transforming growth factor β receptor expression in murine plasmacytomas (Q35671557) (← links)
• Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia (Q36160563) (← links)
• Role of transforming growth factor-beta in hematologic malignancies (Q36399296) (← links)
• Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells (Q38909786) (← links)
• A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma (Q40019241) (← links)
• Effects of transforming growth factor beta (TGF-beta) receptor on lung carcinogenesis (Q40694387) (← links)
• Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells (Q40904544) (← links)
• Transforming growth factor-β in breast cancer: A working hypothesis (Q41096355) (← links)
• Aberrant responses of human lymphocytic neoplasms to cytokine regulation (Q41710790) (← links)
• Intracellular trafficking of transforming growth factor β receptors (Q47397700) (← links)
• Expression of transforming growth factor beta receptors in normal human colon and sporadic adenocarcinomas (Q48019561) (← links)
• Roles of Myosin-Mediated Membrane Trafficking in TGF-β Signaling (Q92596369) (← links)